Fatty Acid Receptors GPR40/GPR84: Two Promising Targets in Kidney Fibrosis

June 14, 2019
Previous Flipbook
Fezagepras (PBI-4050) reduces angio-proliferative pulmonary arterial hypertension
Fezagepras (PBI-4050) reduces angio-proliferative pulmonary arterial hypertension

Next Flipbook
Activation of the Free-fatty Acid Receptor GPR40 Improves Anemia in Mouse Models of Kidney Disease Via a Novel EPO-Independent Mechanism of
Activation of the Free-fatty Acid Receptor GPR40 Improves Anemia in Mouse Models of Kidney Disease Via a Novel EPO-Independent Mechanism of